ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
25 hedge funds and large institutions have $16.1M invested in Elevation Oncology in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less capital invested
Capital invested by funds: $21.5M → $16.1M (-$5.38M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
25
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$81K | |
| 2 | +$38.1K | |
| 3 | +$37.8K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$213 |
Top Sellers
| 1 | -$1.22M | |
| 2 | -$250K | |
| 3 | -$85.4K | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$39.2K |
| 5 |
VF
Virtu Financial
New York
|
-$31K |